Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids

NCT02465814 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Leiomyoma

Interventions

DRUG: Vilaprisan (BAY1002670)
DRUG: Vilaprisan (BAY1002670
DRUG: Vilaprisan (BAY1002670
DRUG: Vilaprisan (BAY1002670)
DRUG: Ulipristal
DRUG: Ulipristal
DRUG: Ulipristal

Sponsor

Bayer